Jiaqian Xu

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy.

Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy.

Journal: Angewandte Chemie (International ed. in English)

Published: February 03, 2026

Characteristics, treatments, and outcomes of adolescents and adults with neuroblastoma: a retrospective study in China.

Characteristics, treatments, and outcomes of adolescents and adults with neuroblastoma: a retrospective study in China.

Journal: Therapeutic advances in medical oncology

Published: October 27, 2024

Reactive Cysteines in Proteins are the Dominant Reductants for Platinum(IV) Prodrug Activation in Live Cells.

Reactive Cysteines in Proteins are the Dominant Reductants for Platinum(IV) Prodrug Activation in Live Cells.

Journal: Angewandte Chemie (International ed. in English)

Published: August 26, 2024

AURKB inhibition induces rhabdomyosarcoma apoptosis and ferroptosis through NPM1/SP1/ACSL5 axis.

AURKB inhibition induces rhabdomyosarcoma apoptosis and ferroptosis through NPM1/SP1/ACSL5 axis.

Journal: JCI insight

Published: May 01, 2024

Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.

Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.

Journal: Frontiers in pharmacology

Published: April 18, 2024

Current therapeutic landscape and resistance mechanisms to larotrectinib.

Current therapeutic landscape and resistance mechanisms to larotrectinib.

Journal: Cancer biology & medicine

Published: February 06, 2024

PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma.

PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma.

Journal: Oncoimmunology

Published: December 21, 2023

Harnessing platinum(IV) prodrugs as versatile photoinitiators and photocrosslinkers for multifunctional hydrogels and protein labeling.

Harnessing platinum(IV) prodrugs as versatile photoinitiators and photocrosslinkers for multifunctional hydrogels and protein labeling.

Journal: Nature communications

Published: September 26, 2023

Comparison of Different Competitive Proteome Profiling Approaches in Target Identification of Covalent Inhibitors.

Comparison of Different Competitive Proteome Profiling Approaches in Target Identification of Covalent Inhibitors.

Journal: Chembiochem : a European journal of chemical biology

Published: July 11, 2022

Quantitative Proteomics Reveals Cellular Off-Targets of a DDR1 Inhibitor.

Quantitative Proteomics Reveals Cellular Off-Targets of a DDR1 Inhibitor.

Journal: ACS medicinal chemistry letters

Published: December 27, 2019

Applications of Activity-Based Protein Profiling (ABPP) and Bioimaging in Drug Discovery.

Applications of Activity-Based Protein Profiling (ABPP) and Bioimaging in Drug Discovery.

Journal: Chemistry, an Asian journal

Published: October 24, 2019

Cell- and Tissue-Based Proteome Profiling and Bioimaging with Probes Derived from a Potent AXL Kinase Inhibitor.

Cell- and Tissue-Based Proteome Profiling and Bioimaging with Probes Derived from a Potent AXL Kinase Inhibitor.

Journal: Chemistry, an Asian journal

Published: April 19, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026